chr6-75908582-A-G
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4
The NM_004999.4(MYO6):c.3367A>G(p.Asn1123Asp) variant causes a missense change. The variant allele was found at a frequency of 0.0000378 in 1,613,666 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004999.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251386Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135868
GnomAD4 exome AF: 0.0000349 AC: 51AN: 1461390Hom.: 0 Cov.: 32 AF XY: 0.0000358 AC XY: 26AN XY: 727008
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152276Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74458
ClinVar
Submissions by phenotype
not provided Uncertain:4
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
- -
This sequence change replaces asparagine, which is neutral and polar, with aspartic acid, which is acidic and polar, at codon 1123 of the MYO6 protein (p.Asn1123Asp). This variant is present in population databases (rs189411232, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with MYO6-related conditions. ClinVar contains an entry for this variant (Variation ID: 228994). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt MYO6 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
not specified Uncertain:1
The p.Asn1123Asp variant in MYO6 has not been previously reported in individuals with hearing loss, but has been identified in 10/66684 of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; rs189 411232). Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, the clinica l significance of the p.Asn1123Asp variant is uncertain. -
MYO6-related disorder Uncertain:1
The MYO6 c.3367A>G variant is predicted to result in the amino acid substitution p.Asn1123Asp. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0070% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at